Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide.
Average yearly return: +36%
On July 29, 2020 Masi reported second-quarter 2020 adjusted earnings per share (EPS) of 85 cents. Earnings improved 11.8% from the year-ago quarter. Total revenues improved 31.1% year over year to $301 million.
| Strong buy | |
| Buy | |
| X | |
| Wait | |
| Sell | |
| Strong sell |
If you found this site useful and want to help keep it alive,
to cover the costs and keep the site free of advertisements! Thank you for your support!
